Literature DB >> 34212215

Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.

Liang Wang1, Yan Hu1, Baohui Song1, Yongjian Xiong2, Jingyu Wang3, Dapeng Chen4.   

Abstract

Janus kinase/signal transduction and transcriptional activator (JAK/STAT) signaling pathway is a transport hub for cytokine secretion and exerts its effects. The activation of JAK/STAT signaling pathway is essential for the regulation of inflammatory responses. Inappropriate activation or deletion of JAK/STAT signaling pathway is the initiator of the inflammatory response. JAK/STAT signaling pathway has been demonstrated to be involved in the process of innate and adaptive immune response to inflammatory bowel disease (IBD). In this review, we discuss the role of the JAK/STAT signaling pathway in the regulation of different cells in IBD, as well as new findings on the involvement of the JAK/STAT signaling pathway in the regulation of the intestinal immune response. The current status of JAK inhibitors in the treatment of IBD is summarized as well. This review highlights natural remedies that can serve as potential JAK inhibitors. These phytochemicals may be useful in the identification of precursor compounds in the process of designing and developing novel JAK inhibitors.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cytokine; Inflammatory bowel disease; Intestinal inflammation; JAK inhibitor; JAK/STAT; Traditional Chinese medicine

Mesh:

Substances:

Year:  2021        PMID: 34212215     DOI: 10.1007/s00011-021-01482-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  64 in total

Review 1.  Targeting the Jak/STAT pathway for immunosuppression.

Authors:  J J O'shea
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 2.  Current and emerging therapeutic targets for IBD.

Authors:  Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-01       Impact factor: 46.802

Review 3.  Small molecule oral targeted therapies in ulcerative colitis.

Authors:  Uday N Shivaji; Olga Maria Nardone; Rosanna Cannatelli; Samuel Cl Smith; Subrata Ghosh; Marietta Iacucci
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-11

Review 4.  Innovations in Oral Therapies for Inflammatory Bowel Disease.

Authors:  Christopher Ma; Robert Battat; Parambir S Dulai; Claire E Parker; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Drugs       Date:  2019-08       Impact factor: 9.546

Review 5.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

Review 6.  Ulcerative colitis.

Authors:  Taku Kobayashi; Britta Siegmund; Catherine Le Berre; Shu Chen Wei; Marc Ferrante; Bo Shen; Charles N Bernstein; Silvio Danese; Laurent Peyrin-Biroulet; Toshifumi Hibi
Journal:  Nat Rev Dis Primers       Date:  2020-09-10       Impact factor: 52.329

7.  Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.

Authors:  Dominik Aschenbrenner; Maria Quaranta; Stephen N Sansom; Holm H Uhlig; Soumya Banerjee; Nicholas Ilott; Joanneke Jansen; Boyd Steere; Yin-Huai Chen; Stephen Ho; Karen Cox; Carolina V Arancibia-Cárcamo; Mark Coles; Eamonn Gaffney; Simon Pl Travis; Lee Denson; Subra Kugathasan; Jochen Schmitz; Fiona Powrie
Journal:  Gut       Date:  2020-10-09       Impact factor: 23.059

8.  Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.

Authors:  Charles N Bernstein; Charles Burchill; Laura E Targownik; Harminder Singh; Leslie L Roos
Journal:  Gastroenterology       Date:  2019-02-14       Impact factor: 22.682

Review 9.  The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

Authors:  Alice Wang; Katelyn Singh; Wael Ibrahim; Brett King; William Damsky
Journal:  Yale J Biol Med       Date:  2020-03-27

10.  Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels.

Authors:  Shilan Wang; Shiyi Zhang; Shimeng Huang; Zhenhua Wu; Jiaman Pang; Yujun Wu; Junjun Wang; Dandan Han
Journal:  Biomed Res Int       Date:  2020-09-16       Impact factor: 3.411

View more
  2 in total

1.  Dietary ellagic acid ameliorated Clostridium perfringens-induced subclinical necrotic enteritis in broilers via regulating inflammation and cecal microbiota.

Authors:  Yu Tang; Xinyue Zhang; Yanan Wang; Yongpeng Guo; Peiqi Zhu; Guiguan Li; Jianyun Zhang; Qiugang Ma; Lihong Zhao
Journal:  J Anim Sci Biotechnol       Date:  2022-04-19

Review 2.  Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects.

Authors:  Asma Ismail Mahmod; Shatha Khaled Haif; Ayah Kamal; Israa A Al-Ataby; Wamidh H Talib
Journal:  Front Nutr       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.